CTL-901

N/A

Report date: 2022/08/30 10:20:02

Base Information

Drug NameCTL-901

Drug Alias NameCancer vaccine-nnovata plcCancer vaccine-ML LaboratoriesCancer vaccine gene therapy-Cobra TherapeuticsCancer vaccine gene therapy-Innovata plcCTL-901

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVectura Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVectura Ltd

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A